Literature DB >> 30279935

Left subclavian and right femoral vein thrombosis in a pregnant patient with antithrombin deficiency.

Chikara Watanabe1, Toshihisa Ichiba1, Hiroshi Naito1.   

Abstract

Pregnancy is well-known risk factor for deep vein thrombosis (DVT), which usually occurs during the third trimester and in the left-sided lower extremity. We present a case of left subclavian and right femoral vein thrombosis in a pregnant woman with a gestational age of 10 weeks. A 39-year-old woman visited the emergency department complaining of acute pain and swelling of the left upper arm and right lower extremity. She showed swelling of the left upper arm and right lower extremity and a low antithrombin level of 40%. Ultrasound examination showed right femoral and left subclavian vein thrombosis. Her DVTs were treated with unfractionated heparin. Five months later, she received a cesarean delivery with intravenous unfractionated heparin and antithrombin replacement to prevent DVT, and she successfully gave birth. A genetic test for antithrombin deficiency confirmed hereditary antithrombin deficiency. DVT during pregnancy can occur in an upper extremity and at multiple sites. An undiagnosed coagulation disorder magnifies the risk of DVT in pregnant patients. We should examine all extremities for which there are complaints of pain and swelling with suspicion of DVT and consecutively search for an underlying coagulation disorder in pregnant patients with unusual clinical features of DVT. <Learning objective: Deep venous thrombosis (DVT) during pregnancy can occur in an upper extremity and at multiple sites. An undiagnosed coagulation disorder magnifies the risk of DVT in pregnant patients. We should examine all extremities for which there are complaints of pain and swelling with suspicion of DVT and consecutively search for an underlying coagulation disorder in pregnant patients with unusual clinical features of DVT.>.

Entities:  

Keywords:  Antithrombin deficiency; Deep vein thrombosis; Pregnancy

Year:  2018        PMID: 30279935      PMCID: PMC6149647          DOI: 10.1016/j.jccase.2018.06.004

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  8 in total

Review 1.  Venous thromboembolic disease and pregnancy.

Authors:  Paul E Marik; Lauren A Plante
Journal:  N Engl J Med       Date:  2008-11-06       Impact factor: 91.245

Review 2.  A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot.

Authors:  W-S Chan; J S Ginsberg
Journal:  J Thromb Haemost       Date:  2006-08       Impact factor: 5.824

3.  Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.

Authors:  P W Friederich; B J Sanson; P Simioni; S Zanardi; M V Huisman; I Kindt; P Prandoni; H R Büller; A Girolami; M H Prins
Journal:  Ann Intern Med       Date:  1996-12-15       Impact factor: 25.391

4.  Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation.

Authors:  J G Ray; W S Chan
Journal:  Obstet Gynecol Surv       Date:  1999-04       Impact factor: 2.347

5.  Incidence and characteristics of venous thromboembolic disease during pregnancy and the postnatal period: a contemporary series.

Authors:  David J O'Connor; Larry A Scher; Nicholas J Gargiulo; Jinsuk Jang; William D Suggs; Evan C Lipsitz
Journal:  Ann Vasc Surg       Date:  2010-08-30       Impact factor: 1.466

6.  Characterization of antithrombin levels in pregnancy.

Authors:  Andra H James; Eleanor Rhee; Betty Thames; Claire S Philipp
Journal:  Thromb Res       Date:  2014-07-23       Impact factor: 3.944

7.  Ultrasonographic diagnosis of symptomatic deep venous thrombosis in pregnancy.

Authors:  J F Polak; D L Wilkinson
Journal:  Am J Obstet Gynecol       Date:  1991-09       Impact factor: 8.661

8.  Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency.

Authors:  Andra H James; Barbara A Konkle; Kenneth A Bauer
Journal:  Int J Womens Health       Date:  2013-05-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.